Classically activated mouse macrophages produce methylglyoxal that induces a TLR4- and RAGE-independent proinflammatory response.

Journal of Leukocyte Biology
Daniel PrantnerStefanie N Vogel

Abstract

The highly reactive compound methylglyoxal (MG) can cause direct damage to cells and tissues by reacting with cellular macromolecules. MG has been identified as a biomarker associated with increased sepsis-induced mortality. Patients undergoing septic shock have significantly elevated circulating MG levels compared to postoperative patients and healthy controls. Furthermore, MG has been implicated in the development of type II diabetes mellitus and Alzheimer's disease. Because MG is generated during glycolysis, we hypothesized that MG may be produced by classically activated (M1) macrophages, possibly contributing to the inflammatory response. LPS and IFN-γ-treated macrophages acquired an M1 phenotype (as evidenced by M1 markers and enhanced glycolysis) and formed MG adducts, MG-H1, MG-H2, and MG-H3, which were detected using antibodies specific for MG-modified proteins (methylglyoxal 5-hydro-5-methylimidazolones). MG adducts were also increased in the lungs of LPS-treated mice. Macrophages treated with LPS and IFN-γ also exhibited decreased expression of glyoxalase 1 (Glo1), an enzyme that metabolizes MG. Concentrations of exogenous, purified MG > 0.5 mM were toxic to macrophages; however, a nontoxic dose of 0.3 mM induced TNF...Continue Reading

References

Nov 1, 1992·Chemical Research in Toxicology·W H KoppenolJ S Beckman
Nov 1, 1992·Archives of Biochemistry and Biophysics·H IschiropoulosJ S Beckman
Mar 1, 1989·Journal of Medical Microbiology·S BaskaranK A Balasubramanian
Aug 5, 1996·Biochemical and Biophysical Research Communications·A OkadoN Taniguchi
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·R Venugopal, A K Jaiswal
Jul 10, 1999·Science·H WangK J Tracey
Mar 3, 2004·Intensive Care Medicine·Paul E Marik, Murugan Raghavan
Nov 9, 2004·Bioorganic Chemistry·Ina NemetLidija Varga-Defterdarović
Feb 15, 2005·Annals of the Rheumatic Diseases·E ManeiroF J Blanco
Apr 9, 2005·American Journal of Physiology. Renal Physiology·Mariana G RoscaMiriam F Weiss
Apr 6, 2006·The Journal of Clinical Investigation·Rajesh K ThimmulappaShyam Biswal
Jul 10, 2007·Biochemical Pharmacology·Mathias LagaKatia Vancompernolle
Nov 29, 2007·Critical Care : the Official Journal of the Critical Care Forum·Emily C LutterlohNoubar Kessimian
Jan 1, 2008·Chemico-biological Interactions·Miklós Péter Kalapos
Jun 13, 2008·Nature Protocols·Thomas D Schmittgen, Kenneth J Livak
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kari Ann ShireyStefanie N Vogel
Oct 10, 2008·American Journal of Physiology. Cell Physiology·Hideyuki YamawakiYukio Hara
Mar 3, 2009·Brain : a Journal of Neurology·Francesc X GuixFrancisco J Muñoz
Jan 29, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yasuhiko YamamotoHiroshi Yamamoto
Mar 29, 2013·Nature·G M TannahillL A J O'Neill
Jun 19, 2013·Journal of Innate Immunity·Ahmed AchouitiTom van der Poll

❮ Previous
Next ❯

Citations

Nov 2, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Daniel PrantnerStefanie N Vogel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Katja ZunkelBabett Bartling
Thrombosis and Haemostasis
Foivos-Filippos TsokanosStephan Herzig
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Arti DharLingyun Wu
© 2021 Meta ULC. All rights reserved